Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force
Importance A 2016 review for the US Preventive Services Task Force (USPSTF) found use
of statins for primary prevention of cardiovascular disease (CVD) was associated with …
of statins for primary prevention of cardiovascular disease (CVD) was associated with …
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …
SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher… - Circulation, 2019 - Am Heart Assoc
The American Heart Association requests that this document be cited as follows: Grundy SM,
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
[HTML][HTML] Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly
Cardiovascular diseases create an important burden on the public health systems,
especially in the elderly, mostly because this group of patients frequently suffer from multiple …
especially in the elderly, mostly because this group of patients frequently suffer from multiple …
Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older
Importance Data are limited regarding statin therapy for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) in adults 75 years and older. Objective To evaluate the …
cardiovascular disease (ASCVD) in adults 75 years and older. Objective To evaluate the …
Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (ewtopia 75) A randomized, controlled trial
Y Ouchi, J Sasaki, H Arai, K Yokote, K Harada… - Circulation, 2019 - Am Heart Assoc
Background: Evidence regarding the primary prevention of coronary artery disease events
by low-density lipoprotein cholesterol (LDL-C) lowering therapy in older individuals, aged≥ …
by low-density lipoprotein cholesterol (LDL-C) lowering therapy in older individuals, aged≥ …
Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
R Ramos, M Comas-Cufí, R Martí-Lluch, E Balló… - bmj, 2018 - bmj.com
Objective To assess whether statin treatment is associated with a reduction in
atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with …
atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with …
[HTML][HTML] International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action
Globally, the number of drug prescriptions is increasing causing more adverse drug events,
which is now a significant cause of mortality, morbidity, and disability that has reached …
which is now a significant cause of mortality, morbidity, and disability that has reached …
Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …
older than 75 years remains a subject of debate with little evidence to support or exclude the …
Association of low‐density lipoprotein cholesterol levels with more than 20‐year risk of cardiovascular and all‐cause mortality in the general population
Background Current cholesterol guidelines have recommended very low low‐density
lipoprotein cholesterol (LDL‐C) treatment targets for people at high risk of cardiovascular …
lipoprotein cholesterol (LDL‐C) treatment targets for people at high risk of cardiovascular …